Description: Shares in Irish drug maker Elan Corp. PLC lost more than half their value Thursday after the company confirmed that a third patient taking its suspended drug Tysabri had contracted a rare neurological disease.

Category: Rare Neurological Disease

Url: http://www.signonsandiego.com/news/business/biotech/20050331-0740-elan.html

Date: Oct 7, 2005

Current Rating: 0.00

Clicks/Hits Received: 0